Ad
related to: gild stock news today
Search results
Results From The WOW.Com Content Network
Gilead reported strong Q3 results and expects a consistent growth trajectory ... The stock is up nearly 6% Thursday, trading at more than $96 per share, compared to a market close price of $91.69 ...
Gilead (GILD) shares are up 4% in late trading on an announcement that the FDA has granted full approval to its remdesivir treatment. Stimulus or No? Plus News from GILD, Earnings from INTC & MAT
Gilead Sciences (GILD) closed at $67.49 in the latest trading session, marking a -0.97% move from the prior day. Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know Skip to ...
Gilead Sciences (GILD) closed the most recent trading day at $66.20, moving -0.21% from the previous trading session. Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know Skip ...
Regulatory and pipeline updates from Gilead (GILD) and Moderna (MRNA) are a few key highlights from the biotech sector during the past week. Biotech Stock Roundup: GILD's Drug News, NVAX & MRNA ...
In the latest trading session, Gilead Sciences (GILD) closed at $65, marking a -0.28% move from the previous day.
Recent data on Gilead's (NASDAQ:GILD) treatment for the novel coronavirus, remdesivir, along with multiple indications that demand for the drug is strong, have caused me to continue to be upbeat ...
For premium support please call: 800-290-4726 more ways to reach us